A National Perspective on the Multidisciplinary Management of Breast Cancer Through the COVID-19 Pandemic

Date/Time: Thursday, May 7, 2020 at 8 PM EDT

This OncLive^® webinar will focus on the impact of COVID-19 in patients with breast cancer and the innovative ways in which treatment has evolved during this time. We will feature a panel of experts from the nation’s leading cancer centers, led by Eric P. Winer, MD, to discuss important topics and key information for treating patients with breast cancer.

Click here to register today!

Topics/Objectives:

• Regional differences in the management of patients with breast cancer during the COVID-19 pandemic
• Institutional best practices for treating patients with breast cancer that have the novel coronavirus or who may be at risk for developing it
• Guidelines on the prioritization and management of patients with breast cancer

Speakers:

Professor, Medicine, Harvard Medical School; Director, Breast Oncology Center, Dana-Farber Cancer Institute; Physician Active Staff, Medicine, Brigham And Women's Hospital; Thompson Chair, Breast Cancer Research, Dana-Farber Cancer Institute

Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research; Deputy Director of Clinical Sciences at Lineberger Comprehensive Cancer Center

Professor, Medicine and Oncology; Chief of the Division of Oncology, Stanford University Medical Center

Chief, Breast Service, Department of Surgery; Anne Burnett Windfohr Chair of Clinical Oncology, Memorial Sloan Kettering Cancer Center; Professor of Surgery, Weill Cornell Medical College

In Association With:

Sponsored By: